[Alpha Tau in PR Newswire] Alpha Tau Medical Announces Full Year 2021 Financial Results and Provides Corporate Update

JERUSALEM, March 28, 2022 /PRNewswire/ — Alpha Tau Medical Ltd. (Nasdaq: DRTS) (Nasdaq: DRTSW), (“Alpha Tau” or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, reported full year 2021 financial results and provided a corporate update.

Read more here.